No Data
No Data
Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
BofA Securities Cuts Price Target on Caribou Biosciences to $11 From $13, Maintains Buy Rating
Caribou Biosciences Price Target Raised to $34 From $26 at Brookline
Caribou Biosciences Hires CFO From Codexis
Press Release: Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer
Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In?
Unlock the Full List